Trump’s Stock Trades Surge to 3,600 in Three Months, Raising Ethics Questions
President Trump’s investment accounts executed more than 3,600 stock trades worth up to $695 million in the first three months of 2026 — an unprecedented level of financial market activity for a sitting U.S. president, according to a CBS News investigation. The disclosure has ignited a firestorm of criticism from ethics experts and bipartisan calls for congressional investigations into potential conflicts of interest.
The Scale of the Trading
The president’s brokerage accounts placed 2,346 purchases and 1,296 sales across 1,026 individual companies and funds between Jan. 6 and March 30, according to an analysis of Trump’s OGE Form 278-T disclosure. The total value of purchases ranged from $126 million to $399 million, while sales totaled between $86 million and $296 million.
Technology stocks dominated the activity, with Microsoft leading at 22 trades, followed by Amazon (21), Meta (20), Netflix (19), AMD (17), and Oracle (17). The most common transaction size was between $15,001 and $50,000, with 998 purchases and 393 sales falling in that range.
Trading accelerated dramatically in March, with 1,565 purchases in that month alone — roughly four times the monthly average in January and February. March 23 was the busiest single day, with 283 purchases and 17 sales, coinciding with the S&P 500 and FTSE index rebalancing.
Timing Concerns Draw Scrutiny
Several trades have drawn particular attention due to their proximity to favorable government actions. On Jan. 6, Trump’s accounts purchased between $500,001 and $1 million of Nvidia stock. The following week, the administration relaxed export controls on Nvidia’s AI chips for China.
Similarly, the accounts purchased Palantir shares in March. On April 7, Trump praised the defense contractor on Truth Social, writing: “Palantir Technologies (PLTR) has proven to have great war fighting capabilities and equipment. Just ask our enemies!!!”
The president’s accounts also bought up to $730,000 in Eli Lilly stock during a period when the drugmaker benefited from several favorable government decisions related to its GLP-1 weight loss drug business, according to the CBS News investigation. KFF Health News separately reported that Trump’s accounts purchased as much as $680,000 in Eli Lilly stock, highlighting the broader pattern of trading in companies affected by government policy.
The Administration’s Defense
Vice President JD Vance defended Trump at a White House briefing on May 19, saying: “The president doesn’t sit at the Oval Office on his computer on his, like, Robinhood account, buying and selling stocks. That’s absurd. He has independent wealth advisors who manage his money,” as reported by IBTimes.
The Trump Organization issued a statement asserting that “neither President Trump, his family, nor The Trump Organization plays any role in selecting, directing, or approving specific investments.” Treasury Secretary Scott Bessent echoed this at a Senate hearing on June 3, stating that Trump is “not sitting in the Oval Office engaging in a high-frequency trading strategy.”
Expert Opinions Divided
David Salem, a portfolio manager at Hedgeye Asset Management, told CBS News the trades likely reflect “classic tax-loss harvesting activity” and “direct indexing” — automated strategies available only to ultra-high-net-worth individuals. He noted that the spike on March 23, an index rebalancing day, supports this theory.
However, Eric Diton, president of The Wealth Alliance, said he could not explain the volume. “I can’t come up with a rationale for that amount of trading for anyone. Thousands of trades in a quarter. I truly can’t explain it. It makes no sense to me,” he told CBS News.
Ethics and Legal Framework
Stock trading by a sitting president is not illegal. Presidents are exempt from a key conflict of interest law that requires other federal officials to recuse themselves from matters affecting their own finances. However, Trump declined to place his assets in a blind trust — breaking with the tradition of modern presidents including Carter, Reagan, both Bushes, Clinton, Obama, and Biden.
Columbia Law School professor Richard Briffault warned of the perception problem: “The concern is he is in a position to make all kinds of decisions that can affect stock prices. Not even decisions — tweets.”
Calls for Legislation
The controversy has renewed momentum for stock trading bans for public officials. Sen. Elizabeth Warren (D-MA) has called for an SEC and DOJ investigation into potential insider trading. Sen. Josh Hawley (R-MO), sponsor of the bipartisan HONEST Act, told CBS News: “I’m supportive of any stock trading ban we could get. My legislation would not apply to this president or anybody currently in office. It would take effect for the executive branch in January of 2029.”
What’s Next
With no evidence of wrongdoing formally established, the debate centers on perception and the unprecedented intersection of presidential power with active financial market participation. The HONEST Act and Sen. Andy Kim’s Restoring Trust in Public Servants Act remain stalled in Congress, but the controversy has given renewed urgency to the push for reform. Whether the SEC or DOJ opens a formal investigation — and whether the political pressure translates into legislative action — remains to be seen.